Diabetes Press Releases

Teaming government lab & start-up to develop the next generation health tracker

Selling diabetic test strips you no longer need can be a smart way to earn some extra cash.

AZ Diabetic is excited to announce the expansion of its product line to include a comprehensive selection of high-quality lancing devices, designed to meet the diverse needs of individuals managing diabetes.

AZ Diabetic, a trusted name in diabetes care, is proud to announce the availability of an extensive selection of insulin devices for home use, including insulin pens and pumps from leading brands such as BD, Medtronic and Tandem Diabetes Care.

AZ Diabetic is proud to announce our extensive range of diabetic foot care products, designed specifically for individuals living with diabetes.

oday, the Australian Chiropractors Association (ACA) announced new research outcomes from a 12-month longitudinal study, 'Back Complaints in the Elderly: Chiropractic – Australia' (BACE:C-A) at CQUniversity revealing the detrimental impact low back...

AZ Diabetic, a leading provider of diabetic supplies in Vienna, Virginia, reaffirms its commitment to supporting individuals living with diabetes by stressing the significance of reliable and accurate diabetic supplies for home use.

In honor of World Book Day, the renowned authors and Culinary Medicine duo are proud to announce the third in a series of Diabetes for Dummies books.

Nova Biomedical announces the U.S. launch of our New Generation StatStrip Glucose Hospital Meter System.

Millions of Americans across the country living with diabetes now have a path to improved glucose management and better health outcomes thanks to AZ Diabetic, a leading Diabetes Management Equipment and Supplies (DMEPOS) provider.

Preverio™ by La Jolla Naturals is a once-daily all-natural supplement that helps support healthy blood sugar levels using the power of Eriomin Citrus Bioflavonoids.

Community celebrates charitable programs for individuals living with Type 1 Diabetes

TEL AVIV, Israel: DreaMed Diabetes LTD. ("DreaMed" or the "Company"), developer of the endo.digital Clinical Decision Support System announced today that it has received its 5th U.S Food and Drug Administration (FDA) clearance that expands the scope of...

New analysis from London Medical Laboratory reveals over one million people are likely to have undiagnosed type 2 diabetes in the UK, yet a simple fingerprick diagnostic test (which can be taken at home) can identify the disease.

Diabetes Solutions: What You Need to Know Diabetes is a persistent disease that impacts how your body turns meals into strength.

The United States Insulin Delivery Devices Market is expected to surpass US$ 10 billion by 2031

DKBmed LLC is working with the University of Texas Southwestern Health Center to produce a quality improvement program targeted towards Dallas-based barbers and clinicians serving communities with large Black and Hispanic populations.

DKBmed, LLC and Med Learning Group (MLG) are partnering again to produce a new suite of educational activities targeted towards primary care providers, ophthalmologists, and other healthcare providers who manage patients at risk or with diabetic...

TempraMed a leading supplier of innovative personal storage solutions for injectable medications, has announced that their US supplier Gericare Pharmaceuticals has reached an agreement to supply veterans with the VIVI Cap through the VA.

Unlock the secret to reversing diabetes-induced hair loss and reclaim your crowning glory.

DKBmed, LLC is partnering with Bellin Health, Community Health Systems (CHS), and the Order of Saint Francis HealthCare (OSF) to implement technology and education to identify patients who have retinopathy related to diabetes.

RE.DOCTOR through its development of Non-Invasive Blood Glucose Monitoring (BGM) has engineered a pre-diabetes solution that is non-invasive, easily accessible, and low cost.

The Centers for Disease Control and Prevention (CDC) states that less than two-thirds of diabetic people visit an eye specialist for an annual dilated ophthalmic exam.

The U.S. Food and Drug Administration (FDA) has cleared Nova Primary as a blood glucose reference analyzer.